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A B S T R A CT  
Application of metal oxide nanoparticles for treatment of melanoma cells and microbes is being 
investigated. Zinc oxide nanoparticles (ZnO NPs) deserve special mention where particles cause 
destruction of melanoma cells with minimal damage to healthy cells. In the present study, pure phase 
ZnO NPs with particle size of 3.1 nm were synthesized by green route using algal extract. Skin 
melanoma (B16F10) cells were treated with synthesized ZnO NP and compared with commercial ZnO 
NPs and analysed for ED50 for cellular viability using 3% (w/v) of the doses. Sensitivity of B16F10 
cells towards green synthesized ZnO NP was found to be more than commercial ZnO NPs. Results 
showed greater reduction in viability of cells exposed to green synthesized ZnO NPs and with 
increasing dose of the ZnO NPs, percentage viability of cells gradually reduced. 50% decrease in cellular 
viability (ED50) was obtained for green synthesized ZnO NP at 3% dose while commercial ZnO 
exhibited ED50 at 6% of doses. The ZnO NP also showed antimicrobial activity against Pseudomonas 
sp. and Staphylococcus sp. Zone of inhibition (ZOI) exhibited by Pseudomonas aeruginosa and Staphylococcus 
aureus for disc diffusion and well diffusion assay was around 10-22 mm and 9-12mm respectively. 
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1 Introduction 
Nanoscience deals with the fine tuning of material properties so as to control size and shape of materials.  
The particles thus developed are known as nanoparticles ranging within particle size from 1 to 100nm [1]. 
Advances in nanotechnology resulted in different types of nanoparticles having diverse chemical and 
physical properties. These nanoparticles are engineered to have desired selectivity, size, shape and 
biocompatibility. Nanoparticles are also used as media in drug delivery as they are engineered to be pH 
sensitive [2]. To increase biocompatibility of orthopedic implants, nanoparticles are being used [3]. Cancer 
is uncontrolled growth of abnormal cells that infiltrates normal body cells. Treatment includes 
chemotherapy, radiotherapy, surgery etc. `which poses serious after effects. Nanomedicines developed 
from metal oxide nanoparticles having high biocompatibility, lesser toxicity and surface functionalization 
are being widely used for targeted drug delivery for cancer cell treatment. Nanomaterials are known to 
destroy tumor cells by generation of ROS reduce its mass [4]. They can diffuse into cancerous cells due to 
the leaky vasculature nature of the cells and cause its apoptosis.  Metal oxide nanoparticles are directly used 
to kill tumor cells [5]. Among various metal oxide nanoparticles widely used, zinc oxide nanoparticles (ZnO 
NPs) have been exploited in field of biotechnology, biomedical research, drug delivery, cellular imaging etc. 
because of their low toxicity and biodegradability. Zinc is an essential nutrient and is safe for invivo 
applications [6]. ZnO NPs are present in sunscreens, cosmetics, food packaging, paints etc. [7]. ZnO 
dissolves slowly in acidic conditions i.e. in tumour cells and in basic condition and releases zinc ion causing 
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apoptosis [8]. This makes ZnO NP suitable for biomedical applications [9].  It has been studied that zinc 
maintains the activity of p53 which is tumor suppressor gene as well as helps in activation of caspase-6 
enzyme thereby regulating apoptosis [10]. Wang et al., reported use of ZnO to be effective against cancer 
cells as it might generate reactive oxygen species (ROS) in cells thereby destroying it [11]. Taninio et al., 
studied ZnO in vitro against human small-cell lung cancer as well as in orthotopic mouse models. The 
authors observed the potential of ZnO by intravenously administering invivo against orthotopic small-cell 
lung cancers without any adverse effect.  Studies have shown ZnO to be more cytotoxic towards cancer 
cells than healthy cells due to more permeation and retention of the particles by cancer cells [12]. ZnO NPs 
have shown to be highly effective on T98G cancer cells, moderately effective on KB cells, and less toxic 
on normal human HEK cells [13]. ZnO NPs increases mitotic i.e. cytogenetic damage and interphase i.e. 
apoptosis death. They induce micronucleus formation in cells thereby helping in designing potent 
anticancer drugs [14].  Intracellular ROS production of melanoma cancer cells was measured with varying 
dose of ZnO NPs. It was observed that the nanoparticle was effective against HepG2 (liver cancer) and 
MCF-7(breast cancer) cells with less than 10% cell viability with 25 μg/mL nanoparticles dose [15]-[16]. 
Apart from being a potential anticancer candidate ZnO also affects growth of both gram positive and gram-
negative bacteria [17]. The nanoparticles are sensitive towards the lipid bilayer of bacteria resulting in 
generation of ROS and cell destruction [18]. 
 Synthesis of ZnO NPs generally involves use of chemicals through various methods like direct 
precipitation, homogeneous precipitation, solvo-thermal method, sono-chemical method, reverse micelles, 
sol gel method, hydrothermal, thermal decomposition, and microwave irradiation etc [19]-[20]. Green 
synthesis of metal oxide nanoparticles is nowadays being widely used for their cost effectiveness and lower 
toxicity. ZnO NPs synthesized from green route are assumed to be more biocompatible than that 
synthesized from chemical and physical methods [5].  ZnO nanoparticles have been synthesized using milky 
latex of Calotropis procera, Aloe vera, Parthenium hysterophorus, Plectranthus amboinicus, Trifolium pratense flower 
extract etc. [21]-[22].   
 In the present study, green synthesis of ZnO NPs was carried out using algal extracts (Anabaena cylindrica) 
obtained from Institute of Biotechnology, Kolkata, India. Anabaena cylindrica belongs to group of 
cyanobacteria or blue-green algae and are photosynthetic in nature and fixes nitrogen. Biologically active 
compounds like mannose rich carbohydrate, amino acids, lipids etc. are present in Anabaena sp. which acts 
as reducing and capping agents in green synthesis of nanoparticles [23]- [24].  This alga has been used for 
synthesis of copper oxide nanoparticles for drinking water treatment [25]. Namvar et al., have studied 
formation of ZnO NPs via green route using brown seaweed, Sargassum muticum and observed its anticancer 
activity on murine cancer cell lines [24].  
In this study, anticancerous activity of the green synthesized zinc oxide nanoparticles (ZnO NPs) was 
observed in skin melanoma cell line (B16F10) obtained from National Centre for Cell Science, Pune, India 
and compared the results with commercial ZnO NPs. Among different metal oxide nanoparticles, zinc is 
more effective for destruction of cancer cells. Zinc Antimicrobial activity of  ZnO NPs  was observed 
against Streptococcus aureus, a gram positive bacteria that causes skin infection, respiratory tract infection and 
food poisoning in humans and Pseudomonas aeruginosa, a gram negative bacteria known to cause serious 
illnesses i.e. hospital-acquired infections  like  ventilator-associated pneumonia and various sepsis.   
2 Materials and methods 
2.1 Preparation of algal extract 
Pure strain of Anabaena cylindrica was obtained from a biotechnology Institute, Kolkata, India. Algae were 
cultured under aseptic conditions with proper illumination and at room temperature inside laminar 
chamber. Algal extract was prepared by boiling dried biomass in distilled water. Extract was then sterilized 
by autoclaving and stored for synthesis of nanoparticles. 
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2.2 Green synthesis of zinc oxide nanoparticles 
Zinc sulphate (ZnSO4.7H2O, Merck, India) was used as starting material for nanoparticle synthesis. Algal 
extract (1:1) was added drop wise to 100 ml of sterilized 1 mM zinc sulphate solution. Solution was stirred 
inside laminar air chamber at 700rpm, pH of the solution being kept at 8.4. The particles produced were 
washed for neutralization, dried overnight at 100ºC and kept in sterile air tight container for further use.     
Commercial zinc oxide nanoparticles were purchased from Sigma Aldrich having particle size of <50nm.  
2.3 Characterization of ZnO NPs 
Synthesized nanoparticles were characterized to observe phase purity for application on cell line. XRD (X-
ray diffraction) analysis of synthesized nanoparticles were carried out and recorded with varying 2θ (10°-
80°) at 25°C in XPERTPRO diffractometer (Philips, PANalytical, Holland) to understand the nature of 
nanoparticles formed. To understand the structural morphology of nanoparticles, FESEM (Field emission 
scanning electron microscope) analysis was performed and recorded microscope (Gemini Zeiss Supra™ 
35VP, Carl Zeiss, Germany). Surface area of nanoparticles was determined in Autosorb1, Quantachrome 
Instruments (USA). FTIR (Fourier transform infrared spectroscopy) spectra were recorded in the range 
between 400 and 4000cm-1 for determining functional groups present in nanoparticles. Information in size, 
shape, particle morphology and composition of particles was obtained from Transmission electron 
microscopic analysis (TEM, Technai G2 30ST, FEI Company, USA). XPS (X-ray photoelectron 
spectroscopy) analysis was performed to understand the chemical state and composition of nanoparticles 
and scanned within binding energy of 0-1100 electron volts (eV) (5000 XPS-analyzer, Versaprobe-II, USA).  
2.4 Anti-microbial activity of ZnO NPs 
Antimicrobial activity of green synthesized ZnO NPs was observed against gram-positive bacteria 
Staphylococcus aureus and gram-negative bacteria Pseudomonas aeruginosa by both disc assay and well diffusion 
method. Mueller-Hinton agar was used as growing media for bacteria. The media was poured in Petri plates 
of about 90 mm thickness and streaked with respective bacteria in triplicates. Paper discs of about 6mm 
diameter impregnated with 100µL of 0.015 mg/ml ZnO NPs dose and was placed on agar plates sparing 
control. The dose was determined from MIC where nanoparticles dose was varied from 0-0.06mg/ml.  For 
well diffusion assay, 4mm size cavity was bored on solidified agar plates containing streaked bacterial cells 
and 100 µL dose of ZnO NPs was poured in each well except for control. Plates were then incubated at 
37°C for 48 hrs. Zone of inhibition was measured for each plates and antibacterial activity was represented 
in terms of bacterial growth inhibited around the area where nanoparticles dose was applied.  
2.5 Cell cultures 
B16F10 cells were obtained from National Centre for Cell Science, Pune, India (NCCS) and used for the 
determination of the anticancer activity and cytotoxicity of ZnO NPs and commercial ZnO NPs. The cells 
were cultured in Minimal Essential Media supplemented with 10% FBS, antibiotic (100U/ml) (Invitrogen, 
Thermo Fisher Scientific Corporation, Massachusetts, USA) in a humidified atmosphere of 5% CO2 at 37°C 
temperature. 
2.6 Cell viability assay 
Skin melanoma cell line B16F10 were plated into 96 well plated at a density of 1x105 cells/well. After 80% 
of confluence, the cells were treated with different doses (1-8%) of green synthesized and commercial ZnO 
NPs (w/v) respectively and incubated for 4 hours. After the incubation period the experimental medium 
was removed and the cells were washed with phosphate buffer saline, followed by incubation with MTT 
working solution (100µg/ml) for 3 hrs. 100μl of DMSO was added into each well of the 96 well plates and 
the cell viability was measured by the absorbance at 595nm by micro-plate reader. 
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2.7 Acridine Orange EtBr assay 
B16F10 cells were plated into 24 well plated at a density of 1x 106 cells/well. After 80% of confluence, the 
cells were treated with 3% and 5% green synthesized and commercial ZnO NPs respectively and incubated 
for 4 hours. After the incubation period the cultured medium was removed and the cells were washed with 
phosphate buffer saline. Then the cells were incubated with Acridine Orange-EtBr working solution 
(100µg/ml) for 30 mins followed by washing with phosphate buffer saline. The images were observed in 
fluorescence Olympus microscope and were captured using Camedia software (E- 20P 5.0Megapixel). The 
percentage for dead and live cells was quantified using at least five fields of cells for each treatment.  
2.8 Estimation of Reactive Oxygen Species (ROS) 
To determine ROS generation, B16F10 cells were plated into 96 well plated at a density of 1x 105 cells /well. 
After 80% of confluence, the cells were treated with 3% and 5% of green synthesized and commercial ZnO 
NPs respectively and incubated for 4 hours. Experimental media was discarded from each seeded well of 
the 96-well plate and 25 µM H2DCFDA in PBS for 30min and was incubated according to the protocol of 
Image-iTTM LIVE Green Reactive Oxygen Species Detection Kit (Invitrogen, USA). The images were 
observed in fluorescence Olympus microscope and were captured using Camedia software (E-20P 
5.0Megapixel). The percentage for ROS generating cells was quantified with respect to phase images where 
at least five fields of cells were quantified for each treatment.  
2.9 Statistical analysis 
Experiments were repeated for at least three times independently. The statistical analysis of the data was 
done using GraphPad Instat-3 (version 3.06, San Diego, California, USA) software. Comparison between 
groups was performed using one-way analysis of variance (ANOVA) followed by Student–Newman–Keuls 
T-test. Data were fitted using Sigma plot (version11.0, GmbH, Germany) represented as means ± SEM. p 
< 0.05 was accepted as level of significance; **** very highly significant p < 0.0001, *** highly significant 
p < 0.001; ** significant p < 0.01; * less significant p < 0.05; NS not significant for p > 0.05. 
3 Results and discussions 
3.1 XRD analysis 
Synthesized zinc oxide nanoparticles had an average particle size of about 3.1 nm (Fig 1) and 23.4 m2/g 
surface area. XRD analysis revealed peak positions with 2θ values at 31.8°, 34.5°, 36.3°, 47.59°, 56.63°, 
62.89°, 66.4°, 67.98°, 69.09° and 76.98° respectively with (100), (002), (101), (102), (110), (103), (002), (112), 
(201) and (202) planes 
are in good agreement 
with standard ZnO as 
obtained from the 
International Center of 
Diffraction Data card 
(JCPDS-36-1451) [26] 
confirming the 
formation of a 
crystalline monoclinic 
structure.  
 
 
 
Figure 1: Particle size distribution of green synthesized ZnO NPs. 
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Diffraction peaks of other phases were not present thereby confirming formation of pure phase of zinc 
oxide nanoparticles (Fig 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: XRD analysis of green synthesized ZnO NPs. 
 
 
 
 
 
 
 
 
 
Figure 3: FTIR analysis of (a) algal cells and (b) ZnO NPs synthesized with algal extract. 
3.2 FTIR analysis 
 FTIR spectrum of algae extract from Fig 3 revealed spectrum range at 3471cm-1 which corresponded to 
presence of bonded and non-bonded O-H group. Peaks at 2964 cm-1 and 2933 cm-1 were due to 
asymmetric CH2-, symmetric CH3 and –CH2- stretching vibrations. Peaks at 2855 cm-1 and 1152 cm-1 
corresponded to CH2-stretching of lipid and carbohydrate. IR vibrations at 1784 cm-1 was due to C=O 
stretching of esters. 881 cm-1, 848 cm-1 and 707 cm-1 corresponded to C-H bending and peak at 624 cm-1 
was due to bending vibration of C-OH and -COO. Result indicates that phytochemicals present in algal 
extract were responsible for synthesis of zinc oxide nanoparticles. IR peaks of ZnO at 3450 cm-1, 2927 cm-
1, 2848 cm-1 corresponded to stretching vibration of bonded and non-bonded O-H groups, asymmetric –
CH2, symmetric –CH3, and CH2- stretching vibrations, -OH stretches respectively. These peaks were 
present in extract which shifted in ZnO particles indicating their role in metal oxide formation. Peaks at 
1753.6 cm-1 and 1626.4 cm-1 corresponded to C=O carboxylic acid stretch and aromatic C=C stretching. 
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There was a shift in peak from 1152 cm-1 of extract to 1110.4 cm-1 in metal oxide which corresponded to 
C-O-C stretching suggesting role of carbohydrate in formation of metal oxide. IR peaks at 872 cm-1 and 
611 cm-1 corresponded to O-H asymmetric stretching vibration and C-N bond respectively. Peak region 
from 400-600 cm-1 is that of ZnO NPs and from IR data, peak at 501 cm-1 corresponded to ZnO NPs 
[27]. 
3.3 FESEM and TEM analysis 
Fig 4 depicted the FESEM micrographs of the nanoparticles It was observed that rod like nano structure 
was formed having dimension of 40-60nm. The micrographs also showed presence of some larger particles 
due to agglomeration with more or less uniform size, shape and morphology. Phase purity was confirmed 
from EDX analysis where broad peaks of Zn were found. TEM analysis (Fig 5) revealed rod like structure 
with minimum agglomerated zinc oxide nanoparticles embedded in algal matrix. SAED (Selected area 
electron diffraction) pattern revealed diffraction rings of monoclinic ZnO [28].  
 
 
 
 
 
 
 
 
 
Figure 4: FESEM and (b) EDX analysis of green synthesized ZnO NPs 
 
 
 
 
 
 
 
 
 
Figure 5: (a) TEM image (b) SAED pattern of green synthesized ZnO NPs. 
  
(a) (b) 
(a) 
(b) 
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3.4 Antimicrobial activity of green synthesized ZnO NPs 
The results as evident from Fig 6, suggested that ZnO NPs was effective against both gram-positive and 
gram-negative bacteria. Zone of inhibition (ZOI) exhibited by Pseudomonas aeruginosa for disc diffusion and 
well diffusion assay showed around 10-22 mm ZOI as compared to control while Staphylococcus aureus 
showed 9-12mm ZOI for disc diffusion assay and well diffusion assay.  Nanoparticles exhibited strong 
antibacterial activity against both gram positive and gram-negative bacteria. Antimicrobial activity of zinc 
oxide nanoparticles is size dependent i.e. with reducing particle size, activity increases. Possible cause of 
action might be due to membrane damage between nanoparticles and cell surfaces resulting in production 
of reactive oxy gen species.  Xie et al. (2011) observed significant change in cell morphology of C. jejuni 
when treated with ZnO particles by SEM analysis [29].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Antimicrobial activity of green synthesized ZnO NPs 
3.5 ZnO NPs treatment reduced viability of skin cancer (melanoma) cells 
To examine whether green synthesized ZnO NPs treatment affects the cellular proliferation/viability, MTT 
assay was performed, with exposure time of 4 hrs with increasing concentration (1%-8%) of both green 
synthesized ZnO NPs and commercial ZnO NPs, on B16F10 melanoma cells. The cell viability was 
measured from the absorbance at 595nm by micro-plate reader. Results showed that B16F10 cells were 
more sensitive to green synthesized ZnO NPs treatments and exhibited a greater reduction in viability of 
cells than commercial ZnO treatments (Figure 7). With increasing dose of the ZnO NP, percentage viability 
of cells gradually reduced significantly. 3% of dose of ZnO NPs showed 50% decrease in cellular viability 
(ED50), while commercial ZnO exhibited ED50 at 6% of doses, indicating superior affectivity of green 
synthesized ZnO NPs over commercial ZnO NPs on cultured cancer cells. The differences in the 
effectiveness of synthesized ZnO NPs and commercial ZnO NPs in cancer cell killing, however gradually 
(a) (b) (c) 
(d) (e) (f) 
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reduced with increasing doses (more than 6%), which might have resulted from increased  
toxicity (Figure 7). Therefore, dose of 3% and 5% was selected for assessing cellular death and ROS activity. 
Namvar et al., observed green synthesized ZnO NPs inhibited proliferation of murine cancer cells in dose 
and time dependant manner, although normal cells were unaffected [24]. Bai et al., observed similar trend 
where increasing the concentration of ZnO NPs resulted decrease in cellular viability of ovarian cancer cells 
[30]. The authors suggested that ZnO NPs results in reduced mitochondrial function and leakage of lactate 
dehydrogenase in addition to generation of ROS. Similar dose dependant cellular viability was observed by 
Wang et al., in pulmonary adenocarcinoma cell line LTEP-a-2 [31].  
 
Figure 7: Cytotoxicity of green synthesized and commercial ZnO NPs for 4 hrs in B16F10 melanoma cells (*** 
highly significant p < 0.001; ** significant p < 0.01; * less significant p < 0.05). 
3.6 ZnO NPs treatment increased cellular death in skin cancer cells 
Acridine orange/EtBr staining was performed for differentiating live cells from dead cells on the basis of 
membrane integrity. Acridine orange stains both live and dead cells, whereas ethidium bromide stains only 
cells that have lost membrane integrity. The cells were treated with 3% and 5% of green synthesized ZnO 
NPs and commercial ZnO NPs and incubated for 4 hours. The cells were then incubated with Acridine 
Orange-EtBr working solution (100µg/ml) for 30 mins followed by washing with phosphate buffer saline. 
The images were observed in fluorescence Olympus microscope. It was observed that intact cell 
membranes (control) showed green fluorescence due to AO uptake by double stranded DNA but apoptotic 
cells had condensed chromatin and damaged cell membrane appeared clumps of green fluorescent spots 
with uniform orange nuclei [25].  ZnO NPs treatments induced cellular apoptosis in a dose dependant 
manner as gradual increase in percentage of dead cells with increasing doses of ZnO NPs (Figure 8a). When 
quantified, it was found that the survival rates were ~40% and ~30% for 3% and 5% doses of green 
synthesized ZnO NPs treatments respectively, whereas with same doses of commercial ZnO NPs, the cell 
survival rate were around 80% and 70% respectively (Figure 8b). Similar trend was observed by Namvar et 
al. and Rahman et al. [24]- [32]. Similar behaviour was also depicted by CuO NPs in mammalian human 
gastric epithelium (AGS) and Chinese hamster ovarian (CHO) cell lines [25].  
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Figure 8: (a) Representative microphotographs showing live (green) and apoptotic cells (orange) after 
exposure of B16F10 melanoma cells to various concentration of  green synthesized and commercial ZnO NPs; 
(b) Quantification of relative percentage of live cells on 4 hours exposure to various concentrations (3%and 
5%) of of  green synthesized and commercial ZnO NPs in B16F10 cells (**** very highly significant p < 
0.0001, *** highly significant p < 0.001; ** significant p < 0.01; * less significant p < 0.05). 
 
 
Control 
3% commercial  ZnO 3% synthesized ZnO NP 
5% commercial ZnO 5%synthesized ZnONP 
(a) 
(b) 
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3.7 ZnO NPs induced oxidative 
stress in skin cancer cells 
To elucidate how cellular death and 
viability are associated with ZnO NPs 
induced oxidative stress, the authors 
looked into live cellular ROS status 
during nanoparticle treatment. 
Generation of intracellular ROS 
causes decrease in antioxidative 
system of the cell which in turn results 
in oxidative damage of cells and 
ultimate cell death [30]. In this study it 
was observed that ZnO NP 
treatments increased the production 
of ROS to a great extent. Significantly 
higher numbers of ROS generating 
cells (in fluorescent dye) was observed 
in green synthesized ZnO NPs 
treatments in comparison to 
commercial ZnO NPs. Nanoparticles 
showed dose dependent elevation of 
ROS generating cells (Figure 9a). The 
images were observed in fluorescence 
Olympus microscope and were 
captured using Camedia software (E-
20P 5.0Megapixel). With the doses of 
3% and 5% respectively, the 
percentage of ROS generating cells 
were 45% and 55% respectively 
(Figure 9b), whereas with the same 
doses commercial ZnO NPs 
exhibited significantly less ROS 
generation (~20% and 30% 
respectively), indicating superior 
affectivity of green synthesized ZnO 
NPs over commercial ZnO NPs in 
inducing oxidative stress mediated 
cellular death of cultured melanoma 
cells. The excessive generation of 
ROS due to damage of mitochondrial 
electron transport chain causes loss of 
balance in protein activity of cells and 
ultimate apoptosis [6].  
Figure 9 (a): Effect of green synthesized and commercial ZnO NPs 
on ROS generation in B16F10 cells; Representative 
microphotographs showing of green synthesized and commercial 
ZnO NPs induced ROS generation in B16F10 cells. 
  
CONTROL 
5% Commercial ZnO 
3% Commercial ZnO 
5% synthesized ZnO NP 
3% synthesized ZnO NP 
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Bai et al. also observed oxidative stress mediated ovarian cancer cell death by ZnO NPs. ROS mediated 
cancer cell death was also observed by other nanoparticles like silver, palladium, graphene etc. [30]-[33]. 
Figure 9 (b): Effect of green synthesized and commercial ZnO NPs on ROS generation in B16F10 cells; 
Quantification of ROS generating cells on 4 hours exposure to various concentrations (3% and 5%) of of  green 
synthesized and commercial ZnO NPs in B16F10 cells (**** very highly significant p < 0.0001, *** highly 
significant p < 0.001; ** significant p < 0.01; * less significant p < 0.05). 
4 Conclusion 
Attempts were undertaken for treatment of melanoma cells and pathogenic microbes using green 
synthesized zinc oxide nanoparticles using algal extract. Under optimized stirring conditions and algal dose, 
nanoparticles of about 3.1nm were formed at 1mM substrate concentration. Antimicrobial activity of 
synthesized nanoparticles was observed against gram positive as well as gram negative, pathogenic bacteria 
i.e. Pseudomonas and Staphylococcus sp. respectively.  The study explored the potential anticancer activity of 
synthesized ZnO NPs on B16F10 melanoma cell line and compared the results with commercially available 
ZnO NPs. 50% cell death was observed with 3% of green synthesized ZnO NPs dose whereas for 
commercial ZnO NPs ED50 was observed at 6% of doses. 45% cells exhibited ROS generation with 3% 
dose of green synthesized ZnO NPs which was only ~20% for same dose of commercial ZnO NPs. The 
results thus suggest higher efficiency of green synthesized ZnO NPs on cancer cell death with lower doses 
having less toxicity and potential application for oxide-based nanoparticles as chemotherapeutics as 
compared with commercial ZnO NPs. However, in vivo studies are warranted to understand the 
effectiveness of green synthesized ZnO NPs against melanoma tumor models to evaluate the therapeutics 
potential. 
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